Position
Are you excited by understanding complex commercial market dynamics within CVD, MASH, Alzheimer’s Disease and CKD as well as assessing the impact of strategic decisions and initiatives? Do you have the analytical skills and experience from the pharmaceutical industry to forecast the performance of Novo Nordisk products globally? Can you process and combine information from multiple sources to synthesize forecasts?
If so, you might be the person that we are looking for.
The position
You will play a pivotal role in leading the long term forecasting efforts within Cardiovascular & Emerging Therapies Area (CETA), to significantly impact critical business decisions that will shape the company's future.
The role offers broad insights into Novo Nordisk’s worldwide business, active participation in cross-functional projects and international collaboration with teams across different functions and geographies, from a key individual contributor perspective.
Your key tasks will include:
Qualifications
To be successful in this role, you will have the following qualifications:
On a personal level, it is important that you can lead a cross-functional forecasting process with multiple stakeholders, work both independently and in teams both as a driver and contributor, and have solid communication and influencing skill.
About the Department
The CETA Insights & Forecasting Department is a part of Cardiovascular and Emerging Therapy Areas (CETA) Commercial Unit, covering CVD, MASH, Alzheimer’s Disease and CKD therapy areas. We’re a team of highly professional experts with a commercial/business/consulting background and different nationalities. We’re responsible for driving two critical functions; Generate key Customer Insights to bring patient- and HCP-level insights into core decisions for strategic brands, patient access and R&D and the other function, where we analyse market dynamics, identify trends/events and forecast market development across the CETA portfolio.
The overall purpose is to drive insightful analyses and recommendations that enable fact-based decision making in senior management and among key stakeholders across Novo Nordisk.
Contact
For further information about this position, please contact Karin Kernø Jørgensen, Global Director CETA Insights & Forecasting at KKQJ@novonordisk.com.
Deadline
Please apply before the 8th of December 2024.
You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV.
To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
Please note that only applications in English will be considered.
Working at Novo Nordisk
Novo Nordisk is its people. We know that life is anything but linear and balancing what is important at different stages of our career is never easy. That’s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 50,000 employees. Together, we go further. Together, we’re life changing.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.